Agata Cova Selected Research

Aftercare (After-Treatment)

12/2016

Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Agata Cova Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 10/2002
12	Melanoma (Melanoma, Malignant) 01/2021 - 10/2002
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Carcinogenesis 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Mucositis 12/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2016
1	Stomatitis 12/2016
1	Lymphoma (Lymphomas) 01/2016
1	Multiple Myeloma 01/2016
1	Adenocarcinoma 05/2004
1	Carcinoma (Carcinomatosis) 10/2003
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2003

Drug/Important Bio-Agent (IBA)

8	Peptides (Polypeptides)IBA 05/2013 - 04/2003
5	MART-1 AntigenIBA 05/2006 - 02/2003
4	HLA-A*02:01 antigenIBA 05/2013 - 04/2003
4	AntigensIBA 05/2013 - 02/2003
3	VaccinesIBA 08/2006 - 10/2002
2	Immune Checkpoint InhibitorsIBA 01/2021 - 12/2018
2	MicroRNAs (MicroRNA)IBA 01/2019 - 12/2018
2	Interleukin-2 (IL2)IBA 05/2013 - 04/2003
2	EpitopesIBA 03/2009 - 04/2003
2	vitespinIBA 08/2006 - 10/2002
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2006 - 05/2004
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2006 - 10/2002
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 12/2018
1	InterleukinsIBA 12/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016
1	Interleukin-6 (Interleukin 6)IBA 12/2016
1	CytokinesIBA 12/2016
1	Death Domain ReceptorsIBA 01/2016
1	Propidium (Propidium Iodide)IBA 01/2016
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2016
1	Annexin A5IBA 01/2016
1	Caspase 3 (Caspase-3)IBA 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2013
1	Cancer VaccinesIBA 12/2012
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2012
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 03/2009
1	EnzymesIBA 08/2006
1	Interferon-alpha (Interferon Alfa)IBA 08/2006
1	sarcoma glycoprotein gp96 rejection antigensIBA 10/2003
1	Epithelial Cell Adhesion MoleculeIBA 10/2003
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2003
1	LigandsIBA 04/2003
1	Immunodominant EpitopesIBA 04/2003
1	Melanoma-Specific AntigensIBA 10/2002

Therapy/Procedure

7	Therapeutics 01/2022 - 06/2012
4	Immunotherapy 01/2021 - 02/2003
1	Immunomodulation 01/2021
1	Aftercare (After-Treatment) 12/2016
1	Drug Therapy (Chemotherapy) 12/2016
1	Radiotherapy 12/2016